跟著怡琳看世界 26
Delta plus: Scientists say too early to tell risk of Covid-19 variant
Delta Plus:科學家說判斷新冠變異的風險還為時過早
monoclonal antibody 單株抗體
potent 有效的
intravenous 靜脈注射的
neutralise 中和
sample 樣本
India's health ministry says studies showed that the so-called Delta plus variant - also known as AY.1 - spreads more easily, binds more easily to lung cells and is potentially resistant to monoclonal antibody therapy, a potent intravenous infusion of antibodies to neutralise the virus.
印度衛生部表示，研究顯示，所謂的Delta Plus變種，也稱作為AY.1，更容易傳播，更容易與肺細胞結合，並且可能對單株抗體療法產生抗藥性-這是一種有效的靜脈內注射抗體中和病毒療法。
The variant is related to the Delta, an existing variant of concern, which was first identified in India last year and is thought to have driven the deadly second wave of infections this summer in India.
這種變種與Delta相關，是一種現有令人擔憂的變種，該變種病毒去年首度在印度被發現，並被認為是在今天夏天引發印度致命性第二波疫情的原因。
The health ministry says the Delta plus variant, first found in India in April, has been detected in around 40 samples from six districts in three states. At least 16 of these samples were found in Maharashtra, one of the states hardest hit by the pandemic.
衛生部表示，Delta Plus變種在4月在印度3個邦的6個地區，大約40個樣本中首度被發現。其中至少有16個樣本在馬哈拉什特拉邦發現的，是受到疫情影響最嚴重的邦。
Delta plus has also been found in nine other countries - USA, UK, Portugal, Switzerland, Japan, Poland, Nepal, Russia and China - compared to the original highly contagious Delta strain, which has now spread to 80 countries.
Delta Plus在其他9個國家，美國、英國、葡萄牙、瑞士、日本、波蘭、尼泊爾、俄羅斯和大陸，也被發現，而最初的高傳染性Delta病毒，已經傳播到80個國家。
文章來源
https://www.bbc.com/news/world-asia-india-57564560
